64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer
Early Phase 1
Recruiting
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05891028
- Locations
- 🇨🇳
Chinese Academy of Medical Science & Peking Union Medical College Hospital, Beijing, Beijing, China
The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients
Phase 4
Recruiting
- Conditions
- Septic Shock
- Interventions
- Drug: norepinephrine+vasopressin
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05886192
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Phase 2
Recruiting
- Conditions
- Paraganglioma, MalignantPheochromocytoma MalignantPheochromocytoma, Metastatic
- Interventions
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT05885399
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT05886205
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05885386
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05883085
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Correlation Between PaCO2 and Respiratory Effort in Patients With COVID-19 With Extracorporeal Membrane Oxygenation
Completed
- Conditions
- COVID-19 Acute Respiratory Distress SyndromeExtracorporeal Membrane Oxygenation ComplicationRespiratory Effort-Related Arousal
- Interventions
- Device: PaCO2
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05882474
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion
Phase 2
Recruiting
- Conditions
- Clear Cell Renal Cell Carcinoma
- Interventions
- Diagnostic Test: 68Ga-NY104 PET/CT
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05879497
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
Phase 2
Recruiting
- Conditions
- Clear Cell Renal Cell Carcinoma
- Interventions
- Diagnostic Test: 68Ga-NY104 PET/CT
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT05879510
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Metastatic Clear Cell Renal Cell Carcinoma
- Interventions
- Diagnostic Test: 68Ga-NY104 PET/CT
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT05879471
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath